Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARγ

被引:514
作者
Ghisletti, Serena
Huang, Wendy
Ogawa, Sumito
Pascual, Gabriel
Lin, Mu-En
Willson, Timothy M.
Rosenfeld, Michael G.
Glass, Christopher K.
机构
[1] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA
[5] GlaxoSmithKline, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1016/j.molcel.2006.11.022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Transrepression is widely utilized to negatively regulate gene expression, but the mechanisms by which different nuclear receptors effect gene and signal-specific transrepression programs remain poorly understood. Here, we report the identification of alternative SUMOylation-dependent mechanisms that enable PPAR gamma and LXRs to negatively regulate overlapping but distinct subsets of proinflammatory genes. Ligand-dependent conjugation of SUMO2/3 to LXRs or SUMO1 to PPAR gamma targets them to promoters of TLR target genes, where they prevent the signal-dependent removal of NCoR corepressor complexes required for transcriptional activation. SUMO1-PPAR gamma and SUMO2/3LXRs inhibit distinct NCoR clearance mechanisms, allowing promoter- and TLR-specific patterns of repression. Mutational analysis and studies of naturally occurring oxysterol ligands indicate that the transactivation and SUMOylation-dependent transrepression activities of LXRs can be independently regulated. These studies define parallel but functionally distinct pathways that are utilized by PPAR gamma and LXRs to differentially regulate complex programs of gene expression that control immunity and homeostasis.
引用
收藏
页码:57 / 70
页数:14
相关论文
共 49 条
[1]
Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-κB and β-amyloid precursor protein [J].
Baek, SH ;
Ohgi, KA ;
Rose, DW ;
Koo, EH ;
Glass, CK ;
Rosenfeld, MG .
CELL, 2002, 110 (01) :55-67
[2]
Crosstalk between LXR and Toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism [J].
Castrillo, A ;
Joseph, SB ;
Vaidya, SA ;
Haberland, M ;
Fogelman, AM ;
Cheng, GH ;
Tontonoz, P .
MOLECULAR CELL, 2003, 12 (04) :805-816
[3]
Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity [J].
Chang, HM ;
Paulson, M ;
Holko, M ;
Rice, CM ;
Williams, BRG ;
Marié, I ;
Levy, DE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (26) :9578-9583
[4]
Regulation of cholesterol 7α-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRα) [J].
Chiang, JYL ;
Kimmel, R ;
Stroup, D .
GENE, 2001, 262 (1-2) :257-265
[5]
Costet P, 2000, J BIOL CHEM, V275, P28240
[6]
Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway [J].
Delerive, P ;
Martin-Nizard, F ;
Chinetti, G ;
Trottein, F ;
Fruchart, JC ;
Najib, J ;
Duriez, P ;
Staels, B .
CIRCULATION RESEARCH, 1999, 85 (05) :394-402
[7]
Control of peroxisome proliferator-activated receptor γ2 stability and activity by SUMOylation [J].
Floyd, ZE ;
Stephens, JM .
OBESITY RESEARCH, 2004, 12 (06) :921-928
[8]
27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells [J].
Fu, X ;
Menke, JG ;
Chen, YL ;
Zhou, GC ;
MacNaul, KL ;
Wright, SD ;
Sparrow, CP ;
Lund, EG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (42) :38378-38387
[9]
Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells [J].
Galon, J ;
Franchimont, D ;
Hiroi, N ;
Frey, G ;
Boettner, A ;
Ehrhart-Bornstein, M ;
O'Shea, JJ ;
Chrousos, GP ;
Bornstein, SR .
FASEB JOURNAL, 2002, 16 (01) :61-71
[10]
Something about SUMO inhibits transcription [J].
Gill, G .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2005, 15 (05) :536-541